Similar conclusions regarding female cancers were reported for endometrial tumours, where MCT1 was suggested as a marker for worse OS and showed a tendency to be associated with RFS and cancer-specific survival (CSS) [43]. The gene discussed is SLC16A1; the disease is endometrium neoplasm.